Page last updated: 2024-08-17

visnagin and Cardiotoxicity

visnagin has been researched along with Cardiotoxicity in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asnani, A; Chen, HH; Chi, A; Cornella-Taracido, I; Johns, DG; Liu, Y; Peterson, RT; Sosnovik, DE; Vohra, A; Wang, H; Wang, Y; Zheng, B1

Other Studies

1 other study(ies) available for visnagin and Cardiotoxicity

ArticleYear
Highly potent visnagin derivatives inhibit Cyp1 and prevent doxorubicin cardiotoxicity.
    JCI insight, 2018, 01-11, Volume: 3, Issue:1

    Topics: Animals; Apoptosis; Cardiotoxicity; Cell Line; Cytochrome P450 Family 1; Doxorubicin; Heart; Khellin; Male; Mice; Mice, Inbred C57BL; Models, Animal; Myocytes, Cardiac; Structure-Activity Relationship; Xenobiotics; Zebrafish

2018